Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Arthritis & Rheumatology
SubField 2:
Immunology
Rank in SubField 1: 653 out of 40,382 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 139,197 | 106,653 |
| Total Cites | 1,244 | 1,545 |
| H-index | 13 | 16 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 70 | 93 |
| Number of Single+First+Last Authored Papers | 152 | 152 |
| Total Cites to Single+First+Last Authored Papers | 266 | 333 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 810 | 909 |
| Ratio of Total Citations to Distinct Citing Papers | 1.54 | 1.70 |
| Self-Citation Percentage |
19.48%
|
|
De Vita, Salvatore
Università degli Studi di Udine, Dipartimento di Area Medica,
Italy
2023 Rank: 123,782
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Arthritis & Rheumatology
SubField 2:
Immunology
Rank in SubField 1: 658 out of 37,656 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 123,782 | 93,509 |
| Total Cites | 1,211 | 1,615 |
| H-index | 15 | 17 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 45 | 45 |
| Total Cites to Single+First Authored Papers | 67 | 105 |
| Number of Single+First+Last Authored Papers | 150 | 150 |
| Total Cites to Single+First+Last Authored Papers | 317 | 432 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 836 | 946 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.71 |
| Self-Citation Percentage |
25.02%
|
|
De Vita, Salvatore
Presidio Ospedaliero Universitario Santa Maria della Misericordia , Udine,
Italy
2022 Rank: 96,079
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Arthritis & Rheumatology
SubField 2:
Immunology
Rank in SubField 1: 551 out of 35,286 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 96,079 | 62,355 |
| Total Cites | 1,277 | 1,843 |
| H-index | 16 | 19 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 44 | 44 |
| Total Cites to Single+First Authored Papers | 85 | 133 |
| Number of Single+First+Last Authored Papers | 145 | 145 |
| Total Cites to Single+First+Last Authored Papers | 388 | 537 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 894 | 1,039 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.77 |
| Self-Citation Percentage |
30.71%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Arthritis & Rheumatology
SubField 2:
Immunology
Rank in SubField 1: 841 out of 29,160 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 169,575 | 98,080 |
| Total Cites | 800 | 1,171 |
| H-index | 13 | 17 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 1 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 83 | 122 |
| Number of Single+First+Last Authored Papers | 126 | 126 |
| Total Cites to Single+First+Last Authored Papers | 275 | 388 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 551 | 696 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.68 |
| Self-Citation Percentage |
31.68%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.